Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Staar ICL Implantable Contact Lens Approvable With Conditions – Panel

This article was originally published in The Gray Sheet

Executive Summary

Staar's Collamer ICL implantable contact lens should be approved for myopia despite concerns over procedure-related endothelial cell loss, FDA's Ophthalmic Devices Panel concluded in an 8-3 vote late on Oct. 3 in Gaithersburg, Maryland

You may also be interested in...



Staar Will Respond To FDA On “Serious, Continuing Violations”

Staar Surgical said it would issue a report to FDA July 15 detailing the firm's plans for resolving a series of quality systems violations

Staar Will Respond To FDA On “Serious, Continuing Violations”

Staar Surgical said it would issue a report to FDA July 15 detailing the firm's plans for resolving a series of quality systems violations

Staar Tackles Compliance Issues; AMO Sets Sights On Overseas Lens Market

Staar Surgical will create a dedicated compliance office as part of an operational restructuring to boost its regulatory standing in the wake of two warning letters issued by FDA since December

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel